People in the News: Charlie Rodi, Steven Hyman | GenomeWeb

Molecular diagnostic company Trovagene has appointed Charlie Rodi to vice president and chief technology officer. Previous positions include director of the Monsanto Genome Sequencing Center and executive vice president of genomics at Sequenom. He has also held positions at G.D. Searle, where he helped use nucleic acid biomarkers in drug development, and at ICx BioSystems, where he helped establish the use of digital PCR in the detection of rare alleles in circulating nucleic acids.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.